Polygenic Hypercholesterolemia and Cardiovascular Disease Risk.
Sharifi M, Futema M, Nair D, Humphries SE.
Curr Cardiol Rep. 2019 Apr 22;21(6):43. doi: 10.1007/s11886-019-1130-z.
Polygenic contribution for familial hypercholesterolemia (FH).
Medeiros AM, Bourbon M.
Curr Opin Lipidol. 2021 Dec 1;32(6):392-395. doi: 10.1097/MOL.0000000000000787.
Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
Tada H, Nohara A, Kawashiri MA.
Curr Opin Lipidol. 2019 Aug;30(4):300-306. doi: 10.1097/QCO.0000000000000563.
Genetic and molecular architecture of familial hypercholesterolemia.
Abifadel M, Boileau C.
J Intern Med. 2023 Feb;293(2):144-165. doi: 10.1111/joim.13577. Epub 2022 Oct 17.
Polygenic Hypercholesterolemia.
Genkil J, Anastasopoulou C, Sharma S.
2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
Jacob E, Hegele RA.
Curr Atheroscler Rep. 2022 Jun;24(6):419-426. doi: 10.1007/s11883-022-01018-6. Epub 2022 Apr 7.
Familial Hypercholesterolemia: Genes and Beyond.
Warden BA, Fazio S, Shapiro MD.
2024 Sep 23. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Polygenic Risk Scores in Familial Hypercholesterolemia.
Rader DJ, Sheth S.
J Am Coll Cardiol. 2019 Jul 30;74(4):523-525. doi: 10.1016/j.jacc.2019.06.006.
Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
Brandts J, Dharmayat KI, Ray KK, Vallejo-Vaz AJ.
Curr Opin Lipidol. 2020 Jun;31(3):111-118. doi: 10.1097/MOL.0000000000000675.
A Modern Approach to Dyslipidemia.
Berberich AJ, Hegele RA.
Endocr Rev. 2022 Jul 13;43(4):611-653. doi: 10.1210/endrev/bnab037.
